Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bad Ass Cannabis is a medical cannabis company primarily operating in the Oklahoma market, specializing in the cultivation, processing, and distribution of high-potency cannabis products. The company produces a diverse portfolio of goods, including premium indoor-grown flower, concentrates, and infused edibles designed for therapeutic use. By utilizing state-of-the-art cultivation and extraction technologies, Bad Ass Cannabis focuses on delivering consistent purity and potency to meet the needs of medical marijuana patients. Their products are lab-tested to ensure safety and efficacy, targeting common indications such as chronic pain, anxiety, and inflammation. The company operates as a vertically integrated entity, managing the production process from seed to final retail-ready product. Bad Ass Cannabis distributes its offerings through a broad network of licensed dispensaries across its primary geographic focus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bad Ass Cannabis Products.